Division of Pharmaceutical Analysis, Center for Drug Evaluation and Research, US Food and Drug Administration, 645 S. Newstead Ave, Saint Louis, MO 63110, United States.
Division of Pharmaceutical Analysis, Center for Drug Evaluation and Research, US Food and Drug Administration, 645 S. Newstead Ave, Saint Louis, MO 63110, United States.
Anal Chim Acta. 2017 Jun 22;973:75-81. doi: 10.1016/j.aca.2017.04.016. Epub 2017 Apr 10.
We present a four-step screening approach for unapproved drugs. The screening approach is both qualitative and quantitative in design in order to determine if the sample under study contains the correct and acceptable amount of the declared active pharmaceutical ingredient. Four commercially-available unapproved antibiotic and antiviral drugs were used in this study. Out of the 40 individual samples tested, 100% of the samples matched for the declared active pharmaceutical ingredient with no false positives. Following this qualitative identification step, a quantitative assay was used to determine the potency of the product. The assay involves dissolving the sample in water and using a partial least squares model to predict the potency of the product. The average Raman potency results for the four products tested were compared with chromatographic reference methods and the spectroscopic data were found to be within ∼1-6% of those obtained with the reference method for the four products tested. The results indicate that aqueous-based Raman assays may be a suitable field-deployable alternative to traditional techniques run in a laboratory environment.
我们提出了一种用于未经批准药物的四步筛选方法。该筛选方法在设计上既具有定性又具有定量,以确定所研究的样品是否含有正确和可接受数量的申报的活性药物成分。本研究使用了四种市售的未经批准的抗生素和抗病毒药物。在测试的 40 个单独样品中,100%的样品与申报的活性药物成分相匹配,没有假阳性。在完成定性鉴定步骤后,使用定量测定法来确定产品的效力。该测定法涉及将样品溶解在水中,并使用偏最小二乘模型来预测产品的效力。对测试的四种产品的平均拉曼效力结果与色谱参考方法进行了比较,发现光谱数据与参考方法获得的数据在四种测试产品中约为 1-6%。结果表明,基于水的拉曼测定法可能是一种适合现场部署的替代传统技术的方法,可在实验室环境中运行。